Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1234 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cephalon to acquire Gemin X Pharma

Gemin X Pharma stockholders could also receive up to $300m in cash payments upon the achievement of certain regulatory and sales milestones. Gemin X Pharma is a privately-held

Watson introduces herpes drug Famciclovir

Famciclovir, an antiviral, is indicated for the treatment for immunocompetent adult patients with herpes labialis (cold sores), genital herpes and for HIV infected adult patients for treatment of

Takeda Pharma introduces Reminyl in Japan

The dementia drug is supplied by Janssen Pharmaceutical under an agreement signed between the companies. As per the terms of the agreement, Reminyl will be marketed by Takeda

Tesaro signs licensing deal with Amgen

Tesaro intends to discover compounds for oncology indication as well as for the treatment of the patients with non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. The